Metabolic Dysfunction-associated Steatotic Liver Disease

The central purpose of the Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) SIG (formerly the NAFLD SIG) is to provide a forum to share ideas, foster collaboration and brainstorm together as an academy of basic and translational investigators. Our mission is to study the pathogenesis, diagnosis, natural history and development of therapeutics for metabolic dysfunction-associated steatotic Liver disease. The MASLD SIG sponsors programs at the AASLD Annual Meeting, identifies emerging topics in MASLD, and supports the educational mission of AASLD. policy.

SIG Leadership

Chair
Mazen Noureddin, MD, MHSc
Vice Chair
Alina M. Allen, MD
Staff Liaisons
Akuender Dot
Patricia Marshall
Associate Lead
Ricketta Clark
Steering Committees
Naim Alkhouri, MD, FAASLD
Grace L. Guo, FAASLD
Yaron Rotman, MD, MSc, FAASLD
Trainee Lead
Nghiem Bao Ha, MD, MAS
Foundation Awardee Member (Ex Officio)s
Gloria Rothenberg, MS, NP, DNP, BS
Robert M Wilechansky, MD